Last reviewed · How we verify
AB PREP
AB PREP is a therapeutic vaccine designed to stimulate an immune response against the SARS-CoV-2 virus.
AB PREP is a therapeutic vaccine designed to stimulate an immune response against the SARS-CoV-2 virus. Used for COVID-19 prevention.
At a glance
| Generic name | AB PREP |
|---|---|
| Also known as | Reglan, K-Phos neutral, and Dulcolax |
| Sponsor | Long Neck Medical Enterprises |
| Drug class | Therapeutic vaccine |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease |
| Phase | Phase 2 |
Mechanism of action
AB PREP works by presenting antigens from the SARS-CoV-2 virus to the immune system, eliciting a specific response to neutralize the virus. This approach aims to provide long-term immunity against COVID-19. The exact mechanism of action is not fully understood, but it is believed to involve the activation of T-cells and the production of antibodies.
Approved indications
- COVID-19 prevention
Common side effects
- Injection site pain
- Fatigue
- Headache
Key clinical trials
- Pan-Viral Screening and Linkage to Care Among GBMSM and Trans Women in Spain
- mLab App Plus: A Randomized Controlled Trial of a Mobile Health (mHealth) Intervention (NA)
- Comparison of Egoscue Versus Pilates Exercises in Patient With Mechanical Low Back Pain (NA)
- What is the Metabolic Intensity of Pilates (NA)
- Safe, Effective, and More Tolerable 16 Tablets Colon Prep
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- AB PREP CI brief — competitive landscape report
- AB PREP updates RSS · CI watch RSS
- Long Neck Medical Enterprises portfolio CI